患有扩散型大B细胞淋巴瘤的患者老年人营养风险指数的预后值:元分析
Chengkun Yan1,2, Yanyou Xie1, Yaqi Hua1,2
1The Second Affiliated Hospital of Nanchang University, 1 Min De Road, Nanchang, 330006, Jiangxi, China.
概括
较低的老年营养风险指数 (GNRI) 与扩散性大B细胞淋巴瘤 (DLBCL) 患者的生存率较差有关. 这一元分析表明,GNRI是DLBCL结果的有价值的预后指标.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 老年病的医生 老年病的医生
背景情况:
- 老年营养风险指数 (GNRI) 在扩散性大B细胞淋巴瘤 (DLBCL) 患者的预后意义尚未得到充分确立.
- 营养状况越来越被认为是影响癌症患者结果的关键因素.
研究的目的:
- 评估GNRI与诊断为DLBCL的患者的长期存活率之间的关联.
- 确定GNRI是否可以作为DLBCL预后的预测生物标志物.
主要方法:
- 进行了一个系统的元分析,搜索主要的电子数据库 (PubMed,Cochrane Library,Embase,Scopus,Web of Science) 到2023年3月20日.
- 使用95%置信区间 (CI) 计算整体存活率 (OS) 和无进展存活率 (PFS) 的聚合危险比率 (HR).
主要成果:
- 该分析包括7项试验,包括2448名DLBCL患者.
- 较低的GNRI与较差的整体存活率 (HR = 1.78,p < 0.01) 和无进展存活率 (HR = 2.31,p < 0.01) 显著相关.
结论:
- 这些发现表明,较低的GNRI是DLBCL患者预后更差的重要预测因素.
- 在DLBCL中,GNRI显示出作为一个有价值的工具来预测生存结果的承诺.
- 需要进一步的大规模,多中心的前性研究来验证这些发现.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
357
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
Cancer Survival Analysis
394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394


